ARW vs KVYO

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of just 3/9, indicating significant concerns in profitability, leverage, and operating efficiency. Despite this, the company shows resilience through solid revenue growth (13% YoY), consistent earnings beats (25.62% average surprise over last 4 quarters), and a reasonable Debt/Equity ratio of 0.48. Valuation appears attractive relative to peers with a P/E of 13.08 versus sector average of 89.76 and a Price/Book under 1, though low margins and declining recent EPS growth (-0.8% QoQ) temper optimism. The stock trades below its Graham Number ($157.92) and intrinsic value estimate ($212.3), suggesting potential undervaluation, but weak profitability metrics and lack of Altman Z-Score data limit confidence in financial stability.

KVYO presents a stark contrast between strong fundamental growth and bearish market sentiment. The Piotroski F-Score of 5/9 indicates stable financial health, supported by a very strong current ratio (4.27) and minimal debt (D/E 0.10). While revenue growth remains robust at 29.6% and EPS growth is explosive (+171.4%), the stock is plagued by a severe technical downtrend and aggressive insider selling by the CEO. The valuation appears attractive on a forward P/E basis (19.89), but the lack of current profitability and negative price momentum offset the bullish analyst consensus.